Clinical trial Recruiting at 2 sites Observational Ages 18 and up

Evaluating muscle weakness in ICU survivors through exercise testing

Official title: Exercise Testing in ICU Survivors to Evaluate ICU-acquired Weakness

Run by University of Manitoba · NCT06193980 · Data updated 2026-11-12

This study is trying to see how problems with blood flow after being in the ICU affect the strength and exercise ability of patients who survived serious illnesses like sepsis and shock.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorUniversity of Manitoba
Academic / other
Locations2 sites (Winnipeg, Manitoba and 1 other locations)
StatusRecruiting
StartedDecember 15, 2023
Main results expectedDecember 2029
Study endsDecember 2029
Registry record updatedJune 15, 2026
Trial IDNCT06193980 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients who have been mechanically ventilated for at least 7 days in the medical or surgical ICU and have been discharged.

Probably not a fit

Patients who are unable to provide consent or have a health trajectory expected to be significantly limited in the next 12 months may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the impact of sepsis and shock on microcirculation in ICU patients, which can lead to long-term muscle weakness known as ICU-acquired weakness (ICU-AW). It involves four follow-up assessments after ICU discharge at 7 days, 3 months, 6 months, and 12 months to evaluate microvascular function using high-resolution near-infrared spectroscopy (NIRS). The study aims to characterize how microvascular dysfunction affects exercise limitations in survivors of intensive care.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and management of muscle weakness in ICU survivors, enhancing their recovery and quality of life.

How similar studies have gone: While the approach of assessing microvascular function in ICU survivors is gaining attention, this specific study's methodology and focus on long-term outcomes may provide novel insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients who have received mechanical ventilation for at least 7 days in the intensive care unit (ICU) and have subsequently been discharged from hospital.

Exclusion Criteria:

* Unable to provide consent
* Trajectory of health expected to be significantly limited in the upcoming 12 months
* those who self-report that they cannot climb at least one flight of stairs due to limited exercise capacity
* have significant orthopedic or musculoskeletal impairment affecting mobility
* have a medical history of neuromuscular disease
* ongoing respiratory limitations (i.e., supplemental oxygen)
* significant heart disease (i.e. ejection fraction less than 30%, unstable ischemic heart disease, severe valvular heart disease)
* a body mass index (BMI) of ≥ 40 kg/m2 (impacting NIRS signal due to adipose tissue thickness)
* if participant's primary residence is a significant distance from the participating study site

Where it's running

  • St. Boniface General Hospital
    Winnipeg, Manitoba, Canada
    Recruiting
  • Health Sciences Centre Winnipeg
    Winnipeg, Manitoba, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.